Alere India launched its world's first and only fingerpick BNP test device named as AlereTM Heart Check System at 2nd World Summit on Echocardiography held recently in New Delhi.

According to Mr Sanjeev Johar, CEO - Alere India, "Heart failure is a complex, chronic condition associated with high mortality, multiple comorbidities, and frequent hospitalizations. It can significantly diminish quality of life, and more than 50% of people living with heart failure die within 4 years of being diagnosed. As a market leader in primary care provider, Alere offers the first line of defense in the battle against heart failure. Early detection can lead to early treatment. With the Alere Heart Check, you can accurately identify heart failure within minutes in your office and have a profound impact on your patients' health and prevent hospitalization and any further financial burden."

With the accurate, easy-to-use  approach, the detection can take place in minutes- right in the clinician's office where a simple blood test will rule out heart diseases. The test is intended to be used as an aid in the diagnosis of congestive heart failure (also referred to as heart failure). It is beneficial in the assessment of severity of congestive heart failure (also referred to as heart failure). It is also important for the risk stratification of patients with acute coronary syndromes. For the risk stratification of patients with heart failure.

The AlereTM Heart Check System enables one to make timely decisions that could help initiate heart failure treatment sooner; prevent hospitalizations for your patients and the associated costs; Identify practice efficiencies that will allow you and your staff to focus on those patients who need your care most.